DE2253274A1 - Mittel zur steigerung der milchleistung - Google Patents
Mittel zur steigerung der milchleistungInfo
- Publication number
- DE2253274A1 DE2253274A1 DE2253274A DE2253274A DE2253274A1 DE 2253274 A1 DE2253274 A1 DE 2253274A1 DE 2253274 A DE2253274 A DE 2253274A DE 2253274 A DE2253274 A DE 2253274A DE 2253274 A1 DE2253274 A1 DE 2253274A1
- Authority
- DE
- Germany
- Prior art keywords
- prolactin
- trh
- minutes
- content
- administration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000008267 milk Substances 0.000 title claims description 22
- 235000013336 milk Nutrition 0.000 title claims description 22
- 210000004080 milk Anatomy 0.000 title claims description 22
- XNSAINXGIQZQOO-SRVKXCTJSA-N protirelin Chemical compound NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H]1NC(=O)CC1)CC1=CN=CN1 XNSAINXGIQZQOO-SRVKXCTJSA-N 0.000 claims description 21
- 241001465754 Metazoa Species 0.000 claims description 16
- 241000283690 Bos taurus Species 0.000 claims description 15
- 235000013365 dairy product Nutrition 0.000 claims description 7
- 238000001990 intravenous administration Methods 0.000 claims description 4
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- 239000003651 drinking water Substances 0.000 claims description 2
- 235000020188 drinking water Nutrition 0.000 claims description 2
- 230000000295 complement effect Effects 0.000 claims 2
- 230000037006 agalactosis Effects 0.000 claims 1
- 230000037213 diet Effects 0.000 claims 1
- 235000005911 diet Nutrition 0.000 claims 1
- 102000003946 Prolactin Human genes 0.000 description 45
- 108010057464 Prolactin Proteins 0.000 description 45
- 229940097325 prolactin Drugs 0.000 description 45
- 238000002347 injection Methods 0.000 description 17
- 239000007924 injection Substances 0.000 description 17
- 210000002381 plasma Anatomy 0.000 description 11
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
- 210000004369 blood Anatomy 0.000 description 8
- 239000008280 blood Substances 0.000 description 8
- 244000309464 bull Species 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 230000006651 lactation Effects 0.000 description 7
- 238000004519 manufacturing process Methods 0.000 description 7
- 210000002966 serum Anatomy 0.000 description 7
- 238000012360 testing method Methods 0.000 description 5
- 230000000474 nursing effect Effects 0.000 description 4
- 210000000481 breast Anatomy 0.000 description 3
- 239000002504 physiological saline solution Substances 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 241000124008 Mammalia Species 0.000 description 2
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 2
- 210000004198 anterior pituitary gland Anatomy 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000035558 fertility Effects 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 238000002203 pretreatment Methods 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 241001494479 Pecora Species 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 239000013043 chemical agent Substances 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 231100000502 fertility decrease Toxicity 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 239000006194 liquid suspension Substances 0.000 description 1
- 210000002596 lutein cell Anatomy 0.000 description 1
- 230000029849 luteinization Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000000186 progesterone Substances 0.000 description 1
- 229960003387 progesterone Drugs 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 235000012431 wafers Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/142—Amino acids; Derivatives thereof
- A23K20/147—Polymeric derivatives, e.g. peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/184—Hormones
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Animal Husbandry (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Endocrinology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Fodder In General (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US19457171A | 1971-11-01 | 1971-11-01 | |
| US29028872A | 1972-09-19 | 1972-09-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE2253274A1 true DE2253274A1 (de) | 1973-05-10 |
Family
ID=26890169
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE2253274A Pending DE2253274A1 (de) | 1971-11-01 | 1972-10-31 | Mittel zur steigerung der milchleistung |
Country Status (9)
| Country | Link |
|---|---|
| JP (1) | JPS4852562A (OSRAM) |
| BE (1) | BE790851A (OSRAM) |
| CA (1) | CA1013612A (OSRAM) |
| DE (1) | DE2253274A1 (OSRAM) |
| DK (1) | DK131227B (OSRAM) |
| FR (1) | FR2161939B1 (OSRAM) |
| GB (1) | GB1395590A (OSRAM) |
| NL (1) | NL7214718A (OSRAM) |
| SE (1) | SE388760B (OSRAM) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0080854A1 (en) * | 1981-11-28 | 1983-06-08 | Pfizer Limited | Method of improving growth of poultry |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8332704D0 (en) * | 1983-12-07 | 1984-01-11 | Pfizer Ltd | Growth promotants for animals |
-
0
- BE BE790851D patent/BE790851A/xx unknown
-
1972
- 1972-10-18 DK DK514772AA patent/DK131227B/da unknown
- 1972-10-26 CA CA154,905A patent/CA1013612A/en not_active Expired
- 1972-10-31 DE DE2253274A patent/DE2253274A1/de active Pending
- 1972-10-31 FR FR7238541A patent/FR2161939B1/fr not_active Expired
- 1972-10-31 SE SE7214084A patent/SE388760B/xx unknown
- 1972-10-31 NL NL7214718A patent/NL7214718A/xx unknown
- 1972-10-31 GB GB5019872A patent/GB1395590A/en not_active Expired
- 1972-11-01 JP JP47108946A patent/JPS4852562A/ja active Pending
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0080854A1 (en) * | 1981-11-28 | 1983-06-08 | Pfizer Limited | Method of improving growth of poultry |
Also Published As
| Publication number | Publication date |
|---|---|
| BE790851A (fr) | 1973-04-30 |
| FR2161939B1 (OSRAM) | 1976-08-20 |
| NL7214718A (OSRAM) | 1973-05-03 |
| SE388760B (sv) | 1976-10-18 |
| JPS4852562A (OSRAM) | 1973-07-24 |
| CA1013612A (en) | 1977-07-12 |
| DK131227B (da) | 1975-06-16 |
| GB1395590A (en) | 1975-05-29 |
| DK131227C (OSRAM) | 1975-11-17 |
| FR2161939A1 (OSRAM) | 1973-07-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Blair-West et al. | Circulatory changes and renin secretion in sheep in response to feeding | |
| DE69325998T2 (de) | Verwendung von beta-hydroxy-beta-methylbutyratsäuere zur förderung der stickstoffzurückhaltung beim menschen | |
| DE69507029T2 (de) | Pharmazeutische zusammensetzungen enthaltend einen opiat antagonist und calcium salze, ihre verwendung zur behandlung von endorphin-vermittelten krankheiten | |
| Karunanayake et al. | Effect of Momordica charantia fruit juice on streptozotocin-induced diabetes in rats | |
| JPH06128154A (ja) | 食品組成物 | |
| KR0145739B1 (ko) | 발포정 | |
| DE3137125C2 (OSRAM) | ||
| Kauppila et al. | Metoclopramide and breast feeding: efficacy and anterior pituitary responses of the mother and the child | |
| DE69000663T2 (de) | Oral verabreichbarer calciumzusatz fuer vieh. | |
| Fischel et al. | Failure of cortisone to affect rate of disappearance of antibody protein. | |
| Thornton | Urea excretion in ruminants. I. Studies in sheep and cattle offered the same diet | |
| DE3348153C2 (OSRAM) | ||
| US4110446A (en) | Method of treating milk fever in dairy cattle with 1,25-dihydroxycholecalciferol | |
| DE60032509T2 (de) | Chrom-histidin-komplexe als nahrungsmittelzusätze | |
| DE3781268T2 (de) | Verwendung von wachstumshormonen zur stickstoffzurueckhaltung bei hypokalorischen bedingungen. | |
| DE2253274A1 (de) | Mittel zur steigerung der milchleistung | |
| DE69131629T2 (de) | Behandlung fehlender milchabsonderung beim menschen | |
| EP0001124A1 (de) | Neue Arzneimittelmischungen zur Verbesserung der Glucoseverwertung in den Zellen und Senkung des Blutzuckerspiegels | |
| EP0113608A1 (fr) | Association permettant d'améliorer l'absorption de divers cations | |
| EP0018550B1 (de) | Mittel zur Behandlung von Muskelerkrankungen | |
| Villalobos et al. | Effect of prolactin suppression on gonadotrophic secretion in the puerperium | |
| DE3904795C2 (de) | Pharmazeutisches Präparat und dessen Verwendung | |
| DE69124382T3 (de) | Authentischen igf-1 und hypokalorische menge von nährstoffen enthaltendes produkt und dessen verwendung zur behandlung kataboler zustände | |
| DE2349186C2 (de) | Arzneimittel zur Verbesserung der Zellatmung, der Herzmuskelleistung und der Hirnfunktion | |
| Bortree et al. | Ascorbic Acid Stimulation in the Blood Plasma of Dairy Cattle Produced by the Ingestion of Chlorobutanol |